230 related articles for article (PubMed ID: 7897364)
1. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment.
Löhr H; Goergen B; Weber W; Gödderz W; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1994 Dec; 44(4):330-5. PubMed ID: 7897364
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants.
Löhr HF; Weber W; Schlaak J; Goergen B; Meyer zum Buschenfelde KH; Gerken G
Hepatology; 1995 Jul; 22(1):61-8. PubMed ID: 7601434
[TBL] [Abstract][Full Text] [Related]
3. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
[TBL] [Abstract][Full Text] [Related]
4. Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children.
Barbera C; Calvo P; Coscia A; Perugini L; Dastoli G; Randone A; Bonino F; Brunetto MR
Pediatr Res; 1994 Sep; 36(3):347-50. PubMed ID: 7528908
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
Talbodec N; Loriot MA; Gigou M; Guigonis V; Boyer N; Bezeaud A; Erlinger S; Benhamou JP; Marcellin P
Liver; 1995 Apr; 15(2):93-8. PubMed ID: 7540713
[TBL] [Abstract][Full Text] [Related]
6. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
Günther S; Paulij W; Meisel H; Will H
Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
[TBL] [Abstract][Full Text] [Related]
8. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
9. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.
Xu J; Brown D; Harrison T; Lin Y; Dusheiko G
Hepatology; 1992 Jun; 15(6):1002-6. PubMed ID: 1592338
[TBL] [Abstract][Full Text] [Related]
10. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
[TBL] [Abstract][Full Text] [Related]
11. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy.
Lin CY; Lin CC; Chang GJ; King CC
Nephron; 1997; 76(2):176-85. PubMed ID: 9200409
[TBL] [Abstract][Full Text] [Related]
12. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B virus mutants--clinical significance].
Blum HE; Moradpour D; vøn Weizsäcker F; Wieland S; Peters T; Rasenack JW
Z Gastroenterol; 1997 May; 35(5):347-55. PubMed ID: 9265394
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
Marinos G; Torre F; Günther S; Thomas MG; Will H; Williams R; Naoumov NV
Gastroenterology; 1996 Jul; 111(1):183-92. PubMed ID: 8698197
[TBL] [Abstract][Full Text] [Related]
15. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.
Chu CM; Yeh CT; Lee CS; Sheen IS; Liaw YF
J Clin Microbiol; 2002 Jan; 40(1):16-21. PubMed ID: 11773086
[TBL] [Abstract][Full Text] [Related]
16. Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B.
Koh KC; Lee HS; Kim CY
Korean J Intern Med; 1994 Jul; 9(2):61-6. PubMed ID: 7865490
[TBL] [Abstract][Full Text] [Related]
17. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.
Sällberg M; Norder H; Magnius LO
J Med Virol; 1990 Jan; 30(1):1-6. PubMed ID: 2303802
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
19. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
Brunetto MR; Giarin MM; Oliveri F; Chiaberge E; Baldi M; Alfarano A; Serra A; Saracco G; Verme G; Will H
Proc Natl Acad Sci U S A; 1991 May; 88(10):4186-90. PubMed ID: 2034663
[TBL] [Abstract][Full Text] [Related]
20. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B.
Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Ito Y; Shinagawa T
Int J Immunopharmacol; 1991; 13(7):969-75. PubMed ID: 1761362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
